The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood.v91.9.3093.3093_3093_3102PMID 9558362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

  1997cited by this paper
• Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

  1997cited by this paper
• Effect of all trans‐retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells

  1997cited by this paper
• All-trans-retinoic acid in acute promyelocytic leukemia.

  1997cited by this paper
• Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

  1997cited by this paper
• Tissue Factor in Health and Disease

  1997cited by this paper
• New strategies for the treatment of acute promyelocytic leukaemia

  1997cited by this paper
• Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction.

  1996cited by this paper
• AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

  1996cited by this paper
• Anticoagulant effects of retinoic acids on leukemia cells.

  1996cited by this paper
• All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4).

  1996cited by this paper
• All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4

  1996cited by this paper
• Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.

  1996cited by this paper
• Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all‐trans‐retinoic acid

  1996cited by this paper
• All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.

  1996cited by this paper
• Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells.

  1995cited by this paper
• Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.

  1995cited by this paper
• Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.

  1995cited by this paper
• All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.

  1995cited by this paper
• Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.

  1995cited by this paper
• All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study

  1994cited by this paper
• All‐trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells

  1994cited by this paper
• Leukocyte-endothelial adhesion molecules.

  1994cited by this paper
• Acute promyelocytic leukemia: from genetics to treatment.

  1994cited by this paper
• Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.

  1994cited by this paper
• Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia.

  1994cited by this paper
• Rapid improvement of coagulopathy by all‐trans retinoic acid in acute promyelocytic leukemia

  1994cited by this paper
• Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.

  1994cited by this paper
• Expression of the annexin VIII gene in acute promyelocytic leukemia.

  1994cited by this paper
• All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.

  1994cited by this paper
• Thrombomodulin Induction by All-trans Retinoic Acid Is Independent of HL-60 Cells Differentiation to Neutrophilic Cells

  1994cited by this paper
• Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group.

  1994cited by this paper
• Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors.

  1994cited by this paper
• Acute promyelocytic leukemia.

  1994cited by this paper
• New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.

  1993cited by this paper
• Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.

  1993cited by this paper
• Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group.

  1993cited by this paper
• Management of acute promyelocytic leukemia

  1993cited by this paper
• Acute promyelocytic leukemia.

  1993cited by this paper
• Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

  1993cited by this paper
• Management of acute promyelocytic leukemia.

  1993cited by this paper
• Specific expression of the annexin VIII gene in acute promyelocytic leukemia.

  1992cited by this paper
• The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

  1992cited by this paper
• Impact of endothelial activation on fibrinolysis and local proteolysis in tissue repair.

  1992cited by this paper
• All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia.

  1992cited by this paper
• All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

  1992cited by this paper
• Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD18): a retinoic acid-inducible gene.

  1992cited by this paper
• Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation.

  1992cited by this paper
• Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.

  1992cited by this paper
• Antiblastic therapy and thrombosis

  1992cited by this paper
• Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor.

  1992cited by this paper
• The tissue factor pathway of blood coagulation.

  1992cited by this paper
• Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP.

  1992cited by this paper
• A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.

  1991cited by this paper
• Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases.

  1991cited by this paper
• Stimulation of Tissue-Type Plasminogen Activator Synthesis by Retinoids in Cultured Human Endothelial Cells and Rat Tissues In Vivo

  1991cited by this paper
• Inhibitory Effect of Retinoids on the Generation of Procoagulant Activity by Blood Mononuclear Phagocytes

  1991cited by this paper
• Cancer Procoagulant in Acute Non Lymphoid Leukemia: Relationship of Enzyme Detection to Disease Activity

  1990cited by this paper
• Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.

  1990cited by this paper
• Structure and function of thrombomodulin: a natural anticoagulant.

  1990cited by this paper
• Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteolysis

  1990cited by this paper
• All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

  1990cited by this paper
• Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients.

  1990cited by this paper
• Global and molecular hemostatic markers in acute myeloid leukemia.

  1990cited by this paper
• Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

  1989cited by this paper
• Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.

  1989cited by this paper
• Tissue factor gene expression in acute myeloblastic leukemia.

  1989cited by this paper
• Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation.

  1989cited by this paper
• The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination

  1989cited by this paper
• Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors.

  1988cited by this paper
• Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia.

  1988cited by this paper
• A new procoagulant in acute leukemia.

  1988cited by this paper
• Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.

  1987cited by this paper
• Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

  1987cited by this paper
• Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation

  1987cited by this paper
• Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

  1986cited by this paper
• Cancer procoagulant in human tumor cells: evidence from melanoma patients.

  1986cited by this paper
• Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

  1986cited by this paper
• Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

  1985cited by this paper
• Cysteine proteinase procoagulant from amnion-chorion.

  1985cited by this paper
• Tumor cell generation of thrombin via functional prothrombinase assembly.

  1985cited by this paper
• Anticoagulant Properties of Purified X-Like Fragments of Human Fibrinogen Produced by Degradation with Leukocyte Elastase

  1984cited by this paper
• Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis

  1984cited by this paper
• Thrombin generation in acute promyelocytic leukemia.

  1984cited by this paper
• Purification and partial characterization of a D-like fragment from human fibrinogen, produced by human leukocyte elastase.

  1983cited by this paper
• Cultured human endothelial cells generate tissue factor in response to endotoxin.

  1983cited by this paper
• Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.

  1982cited by this paper
• Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity.

  1981cited by this paper
• A variant form of hypergranular promyelocytic leukemia (M3)

  1980cited by this paper
• A VARIANT FORM OF HYPERGRANULAR PROMYELOCYTIC LEUKAEMIA (M3)

  1980cited by this paper
• Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.

  1977cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• The Procoagulant Factor of Leukaemic Promyelocytes: Demonstration of Immunologic Cross Reactivity with Human Brain Tissue Factor

  1975cited by this paper
• Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors.

  1975cited by this paper
• Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

  1973cited by this paper

• Clinical and Molecular Profiles and Treatment Outcomes in Patients With Acute Promyelocytic Leukaemia: A Single-Centre Experience

  2025cites this paper
• Budd-chiari syndrome associated with acute promyelocytic leukemia: a case and literature review

  2025cites this paper
• Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus

  2024cites this paper
• Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial

  2024cites this paper
• Phenotypes of Disseminated Intravascular Coagulation

  2023cites this paper
• Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia

  2023cites this paper
• Arteriovenous thrombosis, a complication of induction therapy with all‐trans retinoic acid for acute promyelocytic leukemia: A case report

  2023cites this paper
• Aleukemic Acute Promyelocytic Leukemia: How Concomitant HIV, Hepatitis C, and Chronic Alcohol Use Disorder May Have Hidden an Underlying Malignancy

  2023cites this paper
• Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience

  2023cites this paper
• The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions

  2023cites this paper
• Chemical identification, antioxidant, cholinesterase inhibitory, and cytotoxic properties of fucoidan extracted from Persian Gulf Sargassum angustifolium

  2022influential citation
• Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia

  2022cites this paper
• Acute promyelocytic leukemia presenting as recurrent venous and arterial thrombotic events: a case report and review of the literature

  2021cites this paper
• LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia

  2021cites this paper
• Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico

  2021cites this paper
• Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?

  2021cites this paper
• Evaluación económica del trióxido de arsénico para el tratamiento de leucemia promielocítica aguda

  2020cites this paper
• All-Trans Retinoic Acid Impairs Platelet Function and Thrombus Formation and Inhibits Protein Kinase CßI/δ Phosphorylation

  2019cites this paper
• Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients

  2019cites this paper
• A Case of Acute Promyelocytic Leukemia Leaded to Diagnosis by Occurrence of Phlegmone in Cheek

  2019cites this paper
• Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia

  2019cites this paper
• The Role of Abnormal Hemostasis and Fibrinolysis in Morbidity and Mortality of Acute Promyelocytic Leukemia

  2019cites this paper
• Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

  2018cites this paper
• Chapter 3 Annexin Proteins : Novel Promising Targets for Anticancer Drug Development

  2018cites this paper
• Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility

  2018cites this paper
• The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.

  2018cites this paper
• Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia

  2018cites this paper
• Usefulness of the delta neutrophil index as an ancillary test in the emergency department for the early diagnosis of suspected acute promyelocytic leukemia

  2017cites this paper
• Annexin Proteins: Novel Promising Targets for Anticancer Drug Development

  2017cites this paper
• Rapid detection of t(15;17)(q24;q21) in acute promyelocytic leukaemia by microwave‐assisted fluorescence in situ hybridization

  2017cites this paper
• Acute Promyelocyte Leukemia in A Child Presented With Proptosis: A Case Report And Literature Review

  2017cites this paper
• Recent advances in acute promyelocytic leukaemia

  2017cites this paper
• A review in the treatment of oncologic emergencies

  2016cites this paper
• Arsenic trioxide augments all-trans retinoic acid-induced differentiation of HL-60 cells.

  2016cites this paper
• Platelets in cancer metastasis: To help the “villain” to do evil

  2016cites this paper
• Hemorrhage and thrombosis in acute promyelocytic leukemia: can we currently predict these manifestations?

  2015cites this paper
• Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation

  2015cites this paper
• Prevention of venous thromboembolism in cancer patients

  2015cites this paper
• Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.

  2015cites this paper
• ATRA-induced cerebral sinus thrombosis

  2014cites this paper
• Cancer-related coagulopathies.

  2014cites this paper
• Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment.

  2014cites this paper
• The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.

  2014cites this paper
• Thrombosis and hemostatic abnormalities in hematological malignancies.

  2014cites this paper
• Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.

  2014cites this paper
• The Unique Hemostatic Dysfunction in Acute Promyelocytic Leukemia

  2014cites this paper
• The Unique Hemostatic Dysfunction in Acute Promyelocytic Leukemia

  2014cites this paper
• Recurrent Arterial and Venous Thromboemboli as Initial Presentation of Acute Promyelocytic Leukemia

  2014cites this paper
• Validation of a Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Method for Determination of All-Trans Retinoic Acid in Human Plasma and Its Application to a Bioequivalence Study

  2014cites this paper
• Pathogenetic Mechanism of Thrombosis in Acute Leukemia The Pathogenesis of Thromboembolic Disease in Acute Leukemias

  2014cites this paper
• Comparative study of the efficacy of Wright-Giemsa stain and Liu's stain in the detection of Auer rods in acute promyelocytic leukemia.

  2014cites this paper
• Contemporary Treatment of APL

  2014cites this paper
• Update on Optimal Management of Acute Myeloid Leukemia

  2013cites this paper
• Thrombosis in acute promyelocytic leukemia.

  2013cites this paper
• Coagulopathy in Adult Acute Leukemia at Presentation in National Center of Hematology (NCH), Baghdad

  2013cites this paper
• Acute Promyelocytic Leukemia in a 17yr Male presenting as Intracerebral Haemorrhage

  2013cites this paper
• Acute Promyelocytic Leukemia Presenting as Ischemic Stroke in Young

  2013cites this paper
• Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer

  2013cites this paper
• Retinoic acid alleviates Con A‐induced hepatitis and differentially regulates effector production in NKT cells

  2012cites this paper
• Bleeding and thrombosis in acute promyelocytic leukemia

  2012influential citation
• Characterization of Plasminogen Binding to NB4 Promyelocytic Cells Using Monoclonal Antibodies against Receptor-Induced Binding Sites in Cell-Bound Plasminogen

  2012cites this paper
• Malaltia tromboembòlica venosa en el pacient oncològic: noves formes de presentació clínica i paper dels anticossos antifosfolípid en la seva patogènia

  2012cites this paper
• Chemoprotective effect of all-trans retinoic acid (ATRA) on oxidative stress and lung metastasis induced by benzo(a)pyrene

  2012cites this paper
• ACUTE PROMYELOCYTIC LEUKEMIA IN FOUR YEAR-OLD FEMALE CHILD. A CASE REPORT

  2012cites this paper
• Peroxidase activity and nuclear density analysis (PANDA) in the diagnosis of acute promyelocytic leukaemia

  2012cites this paper
• Venous thromboembolism in cancer patients

  2012cites this paper
• All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia

  2012cites this paper
• Coagulopathy in APL: a step forward?

  2012cites this paper
• Thrombosis and cancer: 40 years of research.

  2012cites this paper
• The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

  2012cites this paper
• Do circulating tumor cells play a role in coagulation and thrombosis?

  2012cites this paper
• The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.

  2011cites this paper
• Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia

  2011cites this paper
• Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studies

  2011cites this paper
• A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia

  2010cites this paper
• PML/RAR-alpha fusion transcript and polyploidy in acute promyelocytic leukemia without t(15;17).

  2010cites this paper
• Disseminated intravascular coagulation in hematologic malignancies.

  2010cites this paper
• Disseminated Intravascular Coagulation in Hematologic Malignancies

  2010cites this paper
• Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells.

  2010cites this paper
• All-trans retinoic acid alleviates hepatic ischemia/reperfusion injury by enhancing manganese superoxide dismutase in rats.

  2010cites this paper
• Thromboembolic complications in malignant haematological disorders.

  2010cites this paper
• PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association

  2010cites this paper
• Clinico-pathological profile of acute promyelocytic leukaemia at Al-Amal Oncology-Haematology Centre, Qatar.

  2010cites this paper
• Coagulopathy in critically ill patients: part 2-soluble clotting factors and hemostatic testing.

  2010cites this paper
• Hemifacial Microsomia: From Gestation to Childhood

  2009cites this paper
• Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

  2009cites this paper
• Isolated central nervous system relapse in acute promyelocytic leukemia (APL)—response

  2009cites this paper
• Thrombosis and cancer: Trousseau syndrome revisited.

  2009cites this paper
• Coagulation abnormalities in acute promyelocytic leukemia

  2009cites this paper
• Coagulation Abnormalities in Malignancy

  2009cites this paper
• The coagulopathy of acute promyelocytic leukaemia revisited.

  2009cites this paper
• Užití all-trans-retinové kyseliny u akutní promyelocytární leukemie - více než úspěšný model cílené léčby v hematoonkologii

  2008cites this paper
• A Comprehensive Review of Acute Promyelocytic Leukemia in Children

  2008cites this paper
• Venous Thromboembolism in Cancer Patients Undergoing Major Surgery

  2008cites this paper
• Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.

  2008cites this paper
• Management of thromboembolism in hematologic malignancies.

  2007cites this paper
• Peroxisome proliferator-activated receptor gamma and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells.

  2007cites this paper
• Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features

  2007cites this paper
• Incidence and Pathogenesis of Thrombosis in Hematologic Malignancies

  2007cites this paper
• Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive review.

  2007cites this paper